Tracked shipping to New Zealand with premium packaging for just NZ$15 

Ship to
New Zealand
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Select your country

Americas

Europe

Rest of the world

portada Our Journey Beyond Sunset Boulevard: Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on "True" Long-Te
Type
Physical Book
Publisher
Language
English
Pages
58
Format
Hardcover
Dimensions
24.4 x 17.0 x 0.6 cm
Weight
0.30 kg.
ISBN13
9781839694158

Our Journey Beyond Sunset Boulevard: Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on "True" Long-Te

Frederick Hall (Author) · Erlinda M. Gordon (Author) · Intechopen · Hardcover

Our Journey Beyond Sunset Boulevard: Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on "True" Long-Te - Gordon, Erlinda M. ; Hall, Frederick

Cheaper New Book Imported to New Zealand
Delivery: 24 Aug - 01 Sep Shipping: 14 to 15 business days.
NZ$ 258.51
Faster New Book Imported to New Zealand
Delivery: 11 Aug - 18 Aug Shipping: 5 to 6 business days.
NZ$ 295.55
Import costs and 15% GST included in the price ✅
NZ$ 258.51

Synopsis "Our Journey Beyond Sunset Boulevard: Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on "True" Long-Te"

The revival of DeltaRex-G (formerly Rexin-G)-the first proactive tumor-hunting/tumor-killing biomedicine of this kind in history-returned active tumor surveillance and a precision-guided "silver bullet" (dnG1 killer gene) to the cancer clinic with "Expanded Access" in 2019. Empowered by US Right-to-Try legislation, while honoring ethical principles of "informed consent," this unique graphic/picturesque presentation of clinical and translational medicine is intended for postmodern (post-Enlightenment) layman readers, including cancer patients, students, researchers, and future practitioners in the field of precision gene-based medicine. Confronting logical fallacies in popular opinion, the authors present newsworthy, up-to-date clinical research documenting the successful management of refractory metastatic cancers with tumor-targeted gene therapy vectors-validating "pathotropic" (disease-seeking) tumor targeting avant la lettre.

Customers reviews

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews